Literature DB >> 19117128

Ultra-high performance liquid chromatography-mass spectrometry for the metabolomic analysis of urine in colorectal cancer.

Yan-Lei Ma1, Huan-Long Qin, Wei-Jie Liu, Jia-Yuan Peng, Long Huang, Xiao-Ping Zhao, Yi-Yu Cheng.   

Abstract

We report here the results of a pilot study in which ultra-high performance liquid chromatography/time-of- flight-mass spectrometry (UPLC/TOF-MS) and multivariate statistical analysis (supervised partial least squares discriminant analysis, PLS-DA) were applied for urinary metabolite profiling and data interpretation. The results of the PLS-DA indicated that the metabolic pattern as a whole was significantly different between the groups of preoperative colorectal cancer (CRC) patients, postoperative CRC patients, and healthy volunteers, respectively. The preoperative group of patients showed significantly increased levels of low-molecular weight compounds (LMC) MW 283 and MW 234 in comparison to the group of healthy volunteers group. After the operation, the levels of these two LMC significantly decreased. These preliminary results suggest that the UPLC-MS-based method coupled with pattern recognition will likely lead to procedures with the potential to be clinically applicable for the diagnosis of CRC and, consequently, to an improvement in patient prognosis. © Springer Science+Business Media, LLC 2008

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19117128     DOI: 10.1007/s10620-008-0665-4

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  24 in total

Review 1.  'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data.

Authors:  J K Nicholson; J C Lindon; E Holmes
Journal:  Xenobiotica       Date:  1999-11       Impact factor: 1.908

2.  Metabolomics takes its place as latest up-and-coming "omic" science.

Authors:  Charlie Schmidt
Journal:  J Natl Cancer Inst       Date:  2004-05-19       Impact factor: 13.506

Review 3.  Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis.

Authors:  John C Lindon; Elaine Holmes; Mary E Bollard; Elizabeth G Stanley; Jeremy K Nicholson
Journal:  Biomarkers       Date:  2004 Jan-Feb       Impact factor: 2.658

Review 4.  Metabonomics: its potential as a tool in toxicology for safety assessment and data integration.

Authors:  J L Griffin; M E Bollard
Journal:  Curr Drug Metab       Date:  2004-10       Impact factor: 3.731

Review 5.  Global strategies to integrate the proteome and metabolome.

Authors:  Alan Saghatelian; Benjamin F Cravatt
Journal:  Curr Opin Chem Biol       Date:  2005-02       Impact factor: 8.822

6.  Peak capacity in gradient ultra performance liquid chromatography (UPLC).

Authors:  Stephen A C Wren
Journal:  J Pharm Biomed Anal       Date:  2005-06-15       Impact factor: 3.935

Review 7.  A bioinformatician's view of the metabolome.

Authors:  Irene Nobeli; Janet M Thornton
Journal:  Bioessays       Date:  2006-05       Impact factor: 4.345

8.  Sexual dimorphism in urinary metabolite profiles of Han Wistar rats revealed by nuclear-magnetic-resonance-based metabonomics.

Authors:  E G Stanley; N J C Bailey; M E Bollard; J N Haselden; C J Waterfield; E Holmes; J K Nicholson
Journal:  Anal Biochem       Date:  2005-02-07       Impact factor: 3.365

9.  Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts.

Authors:  Olaf Beckonert; Hector C Keun; Timothy M D Ebbels; Jacob Bundy; Elaine Holmes; John C Lindon; Jeremy K Nicholson
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

Review 10.  Colorectal cancer screening: today and tomorrow.

Authors:  Kenneth E Hung; Daniel C Chung
Journal:  South Med J       Date:  2006-03       Impact factor: 0.954

View more
  14 in total

1.  (1)H-NMR-based metabolomics of tumor tissue for the metabolic characterization of rat hepatocellular carcinoma formation and metastasis.

Authors:  Juan Wang; Shu Zhang; Zongfang Li; Jun Yang; Chen Huang; Rongrui Liang; Zhongwei Liu; Rui Zhou
Journal:  Tumour Biol       Date:  2010-10-04

Review 2.  Metabolomics: moving to the clinic.

Authors:  Anders Nordström; Rolf Lewensohn
Journal:  J Neuroimmune Pharmacol       Date:  2009-04-28       Impact factor: 4.147

Review 3.  Review of mass spectrometry-based metabolomics in cancer research.

Authors:  David B Liesenfeld; Nina Habermann; Robert W Owen; Augustin Scalbert; Cornelia M Ulrich
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-10-04       Impact factor: 4.254

4.  Changes in urinary metabolic profiles of colorectal cancer patients enrolled in a prospective cohort study (ColoCare).

Authors:  David B Liesenfeld; Nina Habermann; Reka Toth; Robert W Owen; Eva Frei; Jürgen Staffa; Petra Schrotz-King; Karel D Klika; Cornelia M Ulrich
Journal:  Metabolomics       Date:  2014-12-20       Impact factor: 4.290

5.  Beneficial Regulation of Metabolic Profiles by Black Raspberries in Human Colorectal Cancer Patients.

Authors:  Pan Pan; Chad W Skaer; Steven M Stirdivant; Matthew R Young; Gary D Stoner; John F Lechner; Yi-Wen Huang; Li-Shu Wang
Journal:  Cancer Prev Res (Phila)       Date:  2015-06-08

6.  Exploring Metabolic Profile Differences between Colorectal Polyp Patients and Controls Using Seemingly Unrelated Regression.

Authors:  Chen Chen; Lingli Deng; Siwei Wei; G A Nagana Gowda; Haiwei Gu; Elena G Chiorean; Mohammad Abu Zaid; Marietta L Harrison; Joseph F Pekny; Patrick J Loehrer; Dabao Zhang; Min Zhang; Daniel Raftery
Journal:  J Proteome Res       Date:  2015-05-13       Impact factor: 4.466

7.  Metabonomics identifies serum metabolite markers of colorectal cancer.

Authors:  Binbin Tan; Yunping Qiu; Xia Zou; Tianlu Chen; Guoxiang Xie; Yu Cheng; Taotao Dong; Linjing Zhao; Bo Feng; Xiaofang Hu; Lisa X Xu; Aihua Zhao; Menghui Zhang; Guoxiang Cai; Sanjun Cai; Zhanxiang Zhou; Minhua Zheng; Yan Zhang; Wei Jia
Journal:  J Proteome Res       Date:  2013-05-29       Impact factor: 4.466

8.  A prospective study of serum metabolites and colorectal cancer risk.

Authors:  Amanda J Cross; Steven C Moore; Simina Boca; Wen-Yi Huang; Xiaoqin Xiong; Rachael Stolzenberg-Solomon; Rashmi Sinha; Joshua N Sampson
Journal:  Cancer       Date:  2014-06-03       Impact factor: 6.860

9.  Investigation of urinary volatile organic metabolites as potential cancer biomarkers by solid-phase microextraction in combination with gas chromatography-mass spectrometry.

Authors:  C L Silva; M Passos; J S Câmara
Journal:  Br J Cancer       Date:  2011-11-15       Impact factor: 7.640

10.  Urinary Polyamine Biomarker Panels with Machine-Learning Differentiated Colorectal Cancers, Benign Disease, and Healthy Controls.

Authors:  Tetsushi Nakajima; Kenji Katsumata; Hiroshi Kuwabara; Ryoko Soya; Masanobu Enomoto; Tetsuo Ishizaki; Akihiko Tsuchida; Masayo Mori; Kana Hiwatari; Tomoyoshi Soga; Masaru Tomita; Masahiro Sugimoto
Journal:  Int J Mol Sci       Date:  2018-03-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.